Cargando…
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, www.guidetopharmacology.org) and its precursor IUPHAR-DB, have captured expert-curated interactions between targets and ligands from selected papers in pharmacology and drug discovery since 2003. This resource continues to be developed in conjunction wit...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753190/ https://www.ncbi.nlm.nih.gov/pubmed/29149325 http://dx.doi.org/10.1093/nar/gkx1121 |
_version_ | 1783290225952292864 |
---|---|
author | Harding, Simon D Sharman, Joanna L Faccenda, Elena Southan, Chris Pawson, Adam J Ireland, Sam Gray, Alasdair J G Bruce, Liam Alexander, Stephen P H Anderton, Stephen Bryant, Clare Davenport, Anthony P Doerig, Christian Fabbro, Doriano Levi-Schaffer, Francesca Spedding, Michael Davies, Jamie A |
author_facet | Harding, Simon D Sharman, Joanna L Faccenda, Elena Southan, Chris Pawson, Adam J Ireland, Sam Gray, Alasdair J G Bruce, Liam Alexander, Stephen P H Anderton, Stephen Bryant, Clare Davenport, Anthony P Doerig, Christian Fabbro, Doriano Levi-Schaffer, Francesca Spedding, Michael Davies, Jamie A |
author_sort | Harding, Simon D |
collection | PubMed |
description | The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, www.guidetopharmacology.org) and its precursor IUPHAR-DB, have captured expert-curated interactions between targets and ligands from selected papers in pharmacology and drug discovery since 2003. This resource continues to be developed in conjunction with the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS). As previously described, our unique model of content selection and quality control is based on 96 target-class subcommittees comprising 512 scientists collaborating with in-house curators. This update describes content expansion, new features and interoperability improvements introduced in the 10 releases since August 2015. Our relationship matrix now describes ∼9000 ligands, ∼15 000 binding constants, ∼6000 papers and ∼1700 human proteins. As an important addition, we also introduce our newly funded project for the Guide to IMMUNOPHARMACOLOGY (GtoImmuPdb, www.guidetoimmunopharmacology.org). This has been ‘forked’ from the well-established GtoPdb data model and expanded into new types of data related to the immune system and inflammatory processes. This includes new ligands, targets, pathways, cell types and diseases for which we are recruiting new IUPHAR expert committees. Designed as an immunopharmacological gateway, it also has an emphasis on potential therapeutic interventions. |
format | Online Article Text |
id | pubmed-5753190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57531902018-01-05 The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY Harding, Simon D Sharman, Joanna L Faccenda, Elena Southan, Chris Pawson, Adam J Ireland, Sam Gray, Alasdair J G Bruce, Liam Alexander, Stephen P H Anderton, Stephen Bryant, Clare Davenport, Anthony P Doerig, Christian Fabbro, Doriano Levi-Schaffer, Francesca Spedding, Michael Davies, Jamie A Nucleic Acids Res Database Issue The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, www.guidetopharmacology.org) and its precursor IUPHAR-DB, have captured expert-curated interactions between targets and ligands from selected papers in pharmacology and drug discovery since 2003. This resource continues to be developed in conjunction with the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS). As previously described, our unique model of content selection and quality control is based on 96 target-class subcommittees comprising 512 scientists collaborating with in-house curators. This update describes content expansion, new features and interoperability improvements introduced in the 10 releases since August 2015. Our relationship matrix now describes ∼9000 ligands, ∼15 000 binding constants, ∼6000 papers and ∼1700 human proteins. As an important addition, we also introduce our newly funded project for the Guide to IMMUNOPHARMACOLOGY (GtoImmuPdb, www.guidetoimmunopharmacology.org). This has been ‘forked’ from the well-established GtoPdb data model and expanded into new types of data related to the immune system and inflammatory processes. This includes new ligands, targets, pathways, cell types and diseases for which we are recruiting new IUPHAR expert committees. Designed as an immunopharmacological gateway, it also has an emphasis on potential therapeutic interventions. Oxford University Press 2018-01-04 2017-11-15 /pmc/articles/PMC5753190/ /pubmed/29149325 http://dx.doi.org/10.1093/nar/gkx1121 Text en © The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Database Issue Harding, Simon D Sharman, Joanna L Faccenda, Elena Southan, Chris Pawson, Adam J Ireland, Sam Gray, Alasdair J G Bruce, Liam Alexander, Stephen P H Anderton, Stephen Bryant, Clare Davenport, Anthony P Doerig, Christian Fabbro, Doriano Levi-Schaffer, Francesca Spedding, Michael Davies, Jamie A The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY |
title | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY |
title_full | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY |
title_fullStr | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY |
title_full_unstemmed | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY |
title_short | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY |
title_sort | iuphar/bps guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology |
topic | Database Issue |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753190/ https://www.ncbi.nlm.nih.gov/pubmed/29149325 http://dx.doi.org/10.1093/nar/gkx1121 |
work_keys_str_mv | AT hardingsimond theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT sharmanjoannal theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT faccendaelena theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT southanchris theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT pawsonadamj theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT irelandsam theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT grayalasdairjg theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT bruceliam theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT alexanderstephenph theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT andertonstephen theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT bryantclare theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT davenportanthonyp theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT doerigchristian theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT fabbrodoriano theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT levischafferfrancesca theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT speddingmichael theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT daviesjamiea theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT hardingsimond iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT sharmanjoannal iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT faccendaelena iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT southanchris iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT pawsonadamj iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT irelandsam iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT grayalasdairjg iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT bruceliam iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT alexanderstephenph iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT andertonstephen iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT bryantclare iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT davenportanthonyp iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT doerigchristian iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT fabbrodoriano iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT levischafferfrancesca iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT speddingmichael iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT daviesjamiea iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology AT iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology |